KYMR
Price
$56.25
Change
+$2.51 (+4.67%)
Updated
Sep 26 closing price
Capitalization
4.02B
32 days until earnings call
LYRA
Price
$6.47
Change
+$0.11 (+1.73%)
Updated
Sep 26 closing price
Capitalization
10.64M
Interact to see
Advertisement

KYMR vs LYRA

Header iconKYMR vs LYRA Comparison
Open Charts KYMR vs LYRABanner chart's image
Kymera Therapeutics
Price$56.25
Change+$2.51 (+4.67%)
Volume$1.25M
Capitalization4.02B
Lyra Therapeutics
Price$6.47
Change+$0.11 (+1.73%)
Volume$7.27K
Capitalization10.64M
KYMR vs LYRA Comparison Chart in %
Loading...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LYRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KYMR vs. LYRA commentary
Sep 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KYMR is a Buy and LYRA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 29, 2025
Stock price -- (KYMR: $56.25 vs. LYRA: $6.47)
Brand notoriety: KYMR and LYRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KYMR: 171% vs. LYRA: 37%
Market capitalization -- KYMR: $4.02B vs. LYRA: $10.64M
KYMR [@Biotechnology] is valued at $4.02B. LYRA’s [@Biotechnology] market capitalization is $10.64M. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KYMR’s FA Score shows that 0 FA rating(s) are green whileLYRA’s FA Score has 0 green FA rating(s).

  • KYMR’s FA Score: 0 green, 5 red.
  • LYRA’s FA Score: 0 green, 5 red.
According to our system of comparison, both KYMR and LYRA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KYMR’s TA Score shows that 6 TA indicator(s) are bullish while LYRA’s TA Score has 5 bullish TA indicator(s).

  • KYMR’s TA Score: 6 bullish, 4 bearish.
  • LYRA’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, LYRA is a better buy in the short-term than KYMR.

Price Growth

KYMR (@Biotechnology) experienced а +14.49% price change this week, while LYRA (@Biotechnology) price change was +1.89% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.00%. For the same industry, the average monthly price growth was +9.18%, and the average quarterly price growth was +54.60%.

Reported Earning Dates

KYMR is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+4.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($4.02B) has a higher market cap than LYRA($10.6M). KYMR YTD gains are higher at: 39.821 vs. LYRA (-37.306). LYRA has higher annual earnings (EBITDA): -35.34M vs. KYMR (-267.03M). KYMR has more cash in the bank: 665M vs. LYRA (29.8M). LYRA has less debt than KYMR: LYRA (32.5M) vs KYMR (85.7M). KYMR has higher revenues than LYRA: KYMR (44.7M) vs LYRA (770K).
KYMRLYRAKYMR / LYRA
Capitalization4.02B10.6M37,943%
EBITDA-267.03M-35.34M756%
Gain YTD39.821-37.306-107%
P/E RatioN/AN/A-
Revenue44.7M770K5,805%
Total Cash665M29.8M2,232%
Total Debt85.7M32.5M264%
TECHNICAL ANALYSIS
Technical Analysis
KYMRLYRA
RSI
ODDS (%)
Bearish Trend 3 days ago
79%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
82%
Momentum
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
81%
MACD
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
88%
Advances
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 6 days ago
80%
Declines
ODDS (%)
Bearish Trend 27 days ago
88%
Bearish Trend 4 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 3 days ago
87%
Aroon
ODDS (%)
Bullish Trend 3 days ago
86%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LYRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AQMS7.302.38
+48.37%
Aqua Metals Inc
LFVN10.190.20
+2.00%
Lifevantage Corp
DKS228.273.04
+1.35%
Dick's Sporting Goods
IBCP31.530.17
+0.54%
Independent Bank Corp
ICUI118.810.55
+0.47%
ICU Medical

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been closely correlated with NRIX. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if KYMR jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
+4.68%
NRIX - KYMR
67%
Closely correlated
+7.20%
VERA - KYMR
59%
Loosely correlated
+4.60%
CGON - KYMR
55%
Loosely correlated
+2.91%
RGNX - KYMR
54%
Loosely correlated
+3.10%
NUVL - KYMR
54%
Loosely correlated
+4.99%
More

LYRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, LYRA has been closely correlated with ROQAF. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if LYRA jumps, then ROQAF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LYRA
1D Price
Change %
LYRA100%
+1.73%
ROQAF - LYRA
85%
Closely correlated
N/A
EYPT - LYRA
58%
Loosely correlated
+5.38%
VERA - LYRA
53%
Loosely correlated
+4.60%
KYMR - LYRA
51%
Loosely correlated
+4.68%
CLNN - LYRA
39%
Loosely correlated
+0.09%
More